Carna Health Taps Multidisciplinary Healthcare and Technology Experts to Guide the Future of Cardio-Kidney-Metabolic Care
Strategic leadership additions support Carna Health’s continued global growth, building on key partnerships and positioning the company for U.S. market entry
Carna Health, an AI-enabled digital health company revolutionizing Cardio-Kidney-Metabolic (CKM) care, today announced several strategic leadership appointments, including the addition of multidisciplinary healthcare and technology experts as strategic advisors. The appointments bring expertise across AI, business development, technology, and public health to support the company’s continued growth and global expansion, building on strategic partnerships with Siemens Healthineers and Renalytix as Carna Health advances toward U.S. market entry. The strategic advisors will also guide executive leadership as the company expands large-scale CKM prevention programs into new regions and works toward its goal of screening 100 million lives worldwide by 2030.
In addition to the advisors named below, Justin Nguyen has officially joined the company as Chief Product Officer, while Carna Health’s Jose Pereyra will join the Board of Directors.
